Blinatumomab in Relapsed/Refractory Burkitt Lymphoma

Bohler, Jeanne; Bacher, Ulrike; Banz, Yara; Stadelmann, Raphael; Medinger, Michael; Zander, Thilo; Pabst, Thomas (2023). Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers, 15(1), p. 44. MDPI AG 10.3390/cancers15010044

[img]
Preview
Text
cancers-15-00044-v2.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (895kB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Bacher, Vera Ulrike, Banz Wälti, Yara Sarah, Pabst, Thomas Niklaus

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2072-6694

Publisher:

MDPI AG

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

12 Jan 2023 14:18

Last Modified:

14 May 2024 15:54

Publisher DOI:

10.3390/cancers15010044

PubMed ID:

36612039

BORIS DOI:

10.48350/176825

URI:

https://boris.unibe.ch/id/eprint/176825

Actions (login required)

Edit item Edit item
Provide Feedback